Keith Fargo

Keith Fargo

Speaker: Keith Fargo, Director of Scientific Programs and Outreach, Alzheimer’s Association

Date: Thursday, April 26, 2018
Time: 12:30 PM
Place: Procrastinator Theater, Strand Union Building

Title: The Latest in Alzheimer's Research

Sponsoring department: Psychology

Summary:

The cause is urgent, Alzheimer's is the greatest public health challenge of our time. The Alzheimer’s Association leads the global effort to advance Alzheimer’s disease science, bringing together people, research and resources to further the world’s most ambitious Alzheimer’s and dementia research agenda. Driven by the highest-quality science, the Alzheimer’s Association has been involved in every major advancement in Alzheimer’s research over the past 30 years and we to continue to accelerate the pace of discovery, leading the way toward our vision of a world without Alzheimer’s disease. Learn the latest updates in Alzheimer's and dementia research and get information about clinical trials.

About the speaker:

Keith Fargo oversees the Alzheimer’s Association scientific publications, including Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association and the annual Alzheimer’s Disease Facts and Figures report. Additionally, he is responsible for the TrialMatch® program, a service that connects people with ongoing clinical studies in their area, and the Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment (ISTAART). Representing scientists, physicians and other professionals who are active in dementia research, ISTAART is the professional society of the Alzheimer’s Association and facilitates networking and collaboration among its members in order to increase the rate of progress of Alzheimer’s and dementia research.

Dr. Fargo received his Ph.D. from Indiana University and completed a postdoctoral fellowship at Loyola University Stritch School of Medicine. Before joining the Alzheimer’s Association, Dr. Fargo was a researcher with a focus on regenerative processes in the nervous system; he held appointments as a research scientist at the Edward Hines, Jr. VA Hospital Rehabilitation Research & Development Program and as an assistant research professor at the Loyola University Chicago Department of Molecular Pharmacology & Therapeutics.